Baker Bros. Advisors’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Baker Bros. Advisors’s Portfolio VTAE Stock Details VTAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-637,597	Closed	-$13.3M	–	139
2016 Q3	$13.3M	Hold	637,597	–	–	0.12%	47
2016 Q2	$6.88M	Hold	637,597	–	–	0.07%	63
2016 Q1	$4.23M	Buy	637,597 +450,000	+240%	+$4.09M	0.04%	77
2015 Q4	$3.4M	Hold	187,597	–	–	0.03%	90
2015 Q3	$2.06M	Hold	187,597	–	–	0.02%	102
2015 Q2	$2.7M	Hold	187,597	–	–	0.02%	94
2015 Q1	$2.2M	Buy	+187,597	New	+$2.53M	0.02%	102

Baker Bros. Advisors's VTAE Position: Q4 2016 in Review

Baker Bros. Advisors sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 637,597 shares — an estimated $13.3M sold.

Baker Bros. Advisors first reported a position in VTAE in Q1 2015 and held it in 7 quarters. The position peaked at $13.3M in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

Baker Bros. Advisors reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
Baker Bros. Advisors sold 637,597 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $13.3M.
Baker Bros. Advisors first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 7 quarters.
Baker Bros. Advisors's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $13.3M in Q3 2016.
0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Baker Bros. Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.